LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

Terns Clinical Study Site 1002, Baltimore

Terns Clinical Study Site 1027, Durham

Terns Clinical Study Site 1012, Gainesville

Terns Clinical Study Site 1033, Orlando

Terns Clinical Study Site 1007, Hialeah

Terns Clinical Study Site 1028, Hialeah

Terns Clinical Study Site 1009, Miami

Terns Clinical Study Site 1014, Hermitage

Terns Clinical Study Site 1032, Indianapolis

Terns Clinical Study Site 1037, New Orleans

Terns Clinical Study Site 1023, Shreveport

Terns Clinical Study Site 1010, Bastrop

Terns Clinical Study Site 1005, Arlington

Terns Clinical Study Site 1021, Houston

Terns Clinical Study Site 1029, Houston

Terns Clinical Study Site 1006, San Antonio

Terns Clinical Study Site 1003, San Antonio

Terns Clinical Study Site 1019, San Antonio

Terns Clinical Study Site 1025, Georgetown

Terns Clinical Study Site 1017, Chandler

Terns Clinical Study Site 1018, Tucson

Terns Clinical Study Site 1024, Tucson

Terns Clinical Study Site 1016, Los Angeles

Terns Clinical Study Site 1001, Panorama City

Terns Clinical Study Site 1008, Montclair

Terns Clinical Study Site 1013, La Jolla

Terns Clinical Study Site 1004, Coronado

Terns Clinical Study Site 1035, Fresno

Terns Clinical Study Site 1022, Seattle

Terns Clinical Study Site 1011, Boston

Terns Clinical Study Site 1038, Florham Park